指南与共识心血管USMRCT

心力衰竭继发性二尖瓣反流的管理:ESC四学会联合立场声明

The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
指南 / 共识 · Eur Heart J · 2021-01-01

继发性(功能性)二尖瓣反流在射血分数降低的慢性心衰患者中常见,由左室重构导致瓣叶对合不良,可加重心衰症状并恶化预后。该联合立场声明由ESC下属HFA、EACVI、EHRA和EAPCI共同制定,提出基于心脏团队的多学科评估与管理实用路径,强调优化药物与器械治疗、仔细的临床与影像评估,以及审慎解读现有随机试验结果。

要点

  • 继发性二尖瓣反流由左室重构致瓣叶对合不良,可加重心衰症状并恶化预后。
  • 管理需及时转诊至多学科心脏团队,并按指南优化药物与器械治疗。
  • 外科矫正证据稀少且预后获益存疑,经导管修复结果矛盾需审慎解读。

局限性

  • 关于继发性二尖瓣反流外科矫正的证据稀少,且该方式能否改善预后存疑。
  • 经导管修复的现有随机试验结果相互矛盾,需审慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. Secondary mitral regurgitation contributes to progression of the symptoms and signs of HF and confers worse prognosis. The management of HF patients with SMR is complex and requires timely referral to a multidisciplinary Heart Team. Optimization of pharmacological and device therapy according to guideline recommendations is crucial. Further management requires careful clinical and imaging assessment, addressing the anatomical and functional features of the mitral valve and left ventricle, overall HF status, and relevant comorbidities. Evidence concerning surgical correction of SMR is sparse and it is doubtful whether this approach improves prognosis. Transcatheter repair has emerged as a promising alternative, but the conflicting results of current randomized trials require careful interpretation. This collaborative position statement, developed by four key associations of the European Society of Cardiology-the Heart Failure Association (HFA), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association of Cardiovascular Imaging (EACVI), and European Heart Rhythm Association (EHRA)-presents an updated practical approach to the evaluation and management of patients with HF and SMR based upon a Heart Team approach.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Coats AJS, Anker SD, Baumbach A, et al. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur Heart J. 2021. PMID: 33734354. doi:10.1093/eurheartj/ehab086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。